Can Stage 3 Ovarian Cancer Be Treated With Surgery?

Surgery is the standard treatment for Stage 3 ovarian cancer, not an exception reserved for select cases. At this stage, disease has spread beyond the pelvis to the peritoneal surfaces or nearby lymph nodes, yet it remains commonly resectable. Surgery is performed either upfront, when the disease appears operable at diagnosis, or after chemotherapy has reduced tumour volume. Chemotherapy accompanies surgery in essentially all cases at this stage.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Stage 3 does not mean surgery is off the table, it means surgery is central to the plan. The question is not whether to operate but when. If the disease looks resectable on initial imaging, we proceed directly to surgery. If it appears too extensive at first, chemotherapy shrinks it before we operate. Either way, surgery and chemotherapy work together here, this is never surgery in isolation.”

The timing of surgery at Stage 3 depends on how the disease presents at diagnosis.

• Primary debulking : Performed upfront when imaging suggests the disease is resectable, aiming for complete removal at the first operation.
• Interval debulking : Performed after chemotherapy has reduced tumour bulk, making complete removal more achievable in more extensive disease.
• Resectability assessment : Imaging and sometimes diagnostic laparoscopy determine which pathway suits a particular patient’s disease pattern.
• Combined with chemotherapy : Regardless of timing, chemotherapy is given before, after, or on both sides of surgery at this stage.

This decision making sits at the core of proper ovarian cancer treatment at Stage 3, where surgical planning and chemotherapy are coordinated together.

The role surgery plays at Stage 3 goes beyond simply removing visible tumour.

• Complete cytoreduction : Achieving no visible residual disease is the strongest predictor of outcome at this stage, stronger than almost any other single factor.
• Extensive removal : Surgery often extends beyond the ovaries to the omentum, peritoneal implants and, where necessary, portions of bowel.
• Sets up chemotherapy : Reducing tumour burden surgically allows subsequent chemotherapy to work against smaller amounts of remaining disease.
• Not a last resort : Surgery at this stage is a planned, central part of treatment from diagnosis, not something considered only if other options fail.

Understanding how surgery fits within the broader treatment of advanced ovarian cancer clarifies why this stage is treated so proactively.

Dr. Sandeep Nayak is a surgical oncologist with 24 years of experience and a fellowship in laparoscopic and robotic onco-surgery. His approach to Stage 3 ovarian cancer prioritises accurate assessment of resectability at diagnosis, then proceeds to whichever surgical pathway, primary or interval, gives the best chance of complete cytoreduction. This means working closely with medical oncology to coordinate chemotherapy timing around the surgical plan.

At Stage 3, the surgical decision is not whether to operate but how to sequence surgery for the best possible result. A thorough assessment at diagnosis determines whether surgery comes first or after chemotherapy, and either pathway is a legitimate, standard route to complete cytoreduction. Approaching this stage with a clear surgical plan from the outset, rather than treating surgery as a fallback, is what gives patients the strongest realistic chance at a good outcome.

References

1. Primary versus interval debulking in advanced ovarian cancer — National Library of Medicine
2. Impact of complete cytoreduction on survival — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.